Trials / Unknown
UnknownNCT04210973
Comparison of Anyu Peibo With Placebo in Treatment of MDD in China
Efficacy and Safety Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Ⅲ Randomized, Double-Blind, Placebo-Paralleled, Multicenter Clinical Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 266 (estimated)
- Sponsor
- Shanghai Mental Health Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Anyu Peibo Capsule comparing with placebo in the treatment of Chinese Patients with Depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anyu Peibo | Anyu Peibo Capsule, 0.8g twice per day, oral after breakfast and supper |
| DRUG | Placebo | Placebo Capsule, twice per day, oral after breakfast and supper |
Timeline
- Start date
- 2020-01-23
- Primary completion
- 2020-12-01
- Completion
- 2021-05-01
- First posted
- 2019-12-26
- Last updated
- 2020-05-12
Locations
15 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04210973. Inclusion in this directory is not an endorsement.